230 related articles for article (PubMed ID: 29084984)
41. Changes in pattern of immunoglobulin heavy chain gene rearrangement and MIB-1 staining before and after eradication of Helicobacter pylori in gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
Kanda M; Suzumiya J; Ohshima K; Okada M; Tamura K; Kikuchi M
Leuk Lymphoma; 2001 Aug; 42(4):639-47. PubMed ID: 11697492
[TBL] [Abstract][Full Text] [Related]
42. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration.
Nakamura T; Inagaki H; Seto M; Nakamura S
J Gastroenterol; 2003; 38(10):921-9. PubMed ID: 14614598
[TBL] [Abstract][Full Text] [Related]
43. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue.
Roggero E; Zucca E; Pinotti G; Pascarella A; Capella C; Savio A; Pedrinis E; Paterlini A; Venco A; Cavalli F
Ann Intern Med; 1995 May; 122(10):767-9. PubMed ID: 7717599
[TBL] [Abstract][Full Text] [Related]
44. Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection.
Morgner A; Miehlke S; Fischbach W; Schmitt W; Müller-Hermelink H; Greiner A; Thiede C; Schetelig J; Neubauer A; Stolte M; Ehninger G; Bayerdörffer E
J Clin Oncol; 2001 Apr; 19(7):2041-8. PubMed ID: 11283137
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients.
Bilgilier C; Simonitsch-Klupp I; Kiesewetter B; Raderer M; Dolak W; Makristathis A; Steininger C
Ann Hematol; 2016 Jun; 95(7):1115-20. PubMed ID: 27091350
[TBL] [Abstract][Full Text] [Related]
46. Patients with Helicobacter pylori negative gastric marginal zone b-cell lymphoma (MZBCL) of MALT have a good prognosis.
Al-Taie O; Al-Taie E; Fischbach W
Z Gastroenterol; 2014 Dec; 52(12):1389-93. PubMed ID: 25474277
[TBL] [Abstract][Full Text] [Related]
47. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
[TBL] [Abstract][Full Text] [Related]
48. [Gastric Mucosa-associated Lymphoid Tissue Lymphoma Based on Outcome of Domestic Treatment].
Jung JT
Korean J Gastroenterol; 2016 Oct; 68(4):175-178. PubMed ID: 27780940
[TBL] [Abstract][Full Text] [Related]
49. Novel Insights of Lymphomagenesis of
Kuo SH; Wu MS; Yeh KH; Lin CW; Hsu PN; Chen LT; Cheng AL
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30999581
[TBL] [Abstract][Full Text] [Related]
50. A retrospective study of 5-year outcomes of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
Abe S; Oda I; Inaba K; Suzuki H; Yoshinaga S; Nonaka S; Morota M; Murakami N; Itami J; Kobayashi Y; Maeshima AM; Saito Y
Jpn J Clin Oncol; 2013 Sep; 43(9):917-22. PubMed ID: 23878345
[TBL] [Abstract][Full Text] [Related]
51. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.
Hong SS; Jung HY; Choi KD; Song HJ; Lee GH; Oh TH; Jo JY; Kim KJ; Byeon JS; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI
Helicobacter; 2006 Dec; 11(6):569-73. PubMed ID: 17083379
[TBL] [Abstract][Full Text] [Related]
52. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
[TBL] [Abstract][Full Text] [Related]
53. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori.
Nakamura S; Matsumoto T; Suekane H; Takeshita M; Hizawa K; Kawasaki M; Yao T; Tsuneyoshi M; Iida M; Fujishima M
Gut; 2001 Apr; 48(4):454-60. PubMed ID: 11247887
[TBL] [Abstract][Full Text] [Related]
54. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Begum S; Sano T; Endo H; Kawamata H; Urakami Y
J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
[TBL] [Abstract][Full Text] [Related]
55. Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan.
Ishikura N; Usui Y; Ito H; Kasugai Y; Oze I; Kato S; Yatabe Y; Nakamura S; Matsuo K
Ann Hematol; 2019 Aug; 98(8):1981-1987. PubMed ID: 31177299
[TBL] [Abstract][Full Text] [Related]
56. Antisecretory medication is associated with decreased Helicobacter pylori detection in gastric marginal zone lymphoma.
Schaberg KB; Evans MF; Wilcox R; Lewis MR
Ann Diagn Pathol; 2015 Dec; 19(6):397-402. PubMed ID: 26615705
[TBL] [Abstract][Full Text] [Related]
57. Eradication therapy in Helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients: a systematic review.
Zullo A; Hassan C; Ridola L; De Francesco V; Rossi L; Tomao S; Vaira D; Genta RM
J Clin Gastroenterol; 2013; 47(10):824-7. PubMed ID: 23442842
[TBL] [Abstract][Full Text] [Related]
58. Second cancers and residual disease in patients treated for gastric mucosa-associated lymphoid tissue lymphoma by Helicobacter pylori eradication and followed for 10 years.
Wündisch T; Dieckhoff P; Greene B; Thiede C; Wilhelm C; Stolte M; Neubauer A
Gastroenterology; 2012 Oct; 143(4):936-42; quiz e13-4. PubMed ID: 22750463
[TBL] [Abstract][Full Text] [Related]
59. A clinicopathologic study of gastric mucosa-associated lymphoid tissue lymphoma.
Ohashi S; Segawa K; Okamura S; Urano H; Kanamori S; Ishikawa H; Hara K; Hukutomi A; Shirai K; Maeda M
Cancer; 2000 May; 88(10):2210-9. PubMed ID: 10820341
[TBL] [Abstract][Full Text] [Related]
60. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial.
Steinbach G; Ford R; Glober G; Sample D; Hagemeister FB; Lynch PM; McLaughlin PW; Rodriguez MA; Romaguera JE; Sarris AH; Younes A; Luthra R; Manning JT; Johnson CM; Lahoti S; Shen Y; Lee JE; Winn RJ; Genta RM; Graham DY; Cabanillas FF
Ann Intern Med; 1999 Jul; 131(2):88-95. PubMed ID: 10419446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
